Treatment of hamster pancreatic cancer with α-difluoromethylornithine, an inhibitor of polyamine biosynthesis

Marilyn Marx, Courtney Townsend, S. C. Barranco, E. J. Glass, J. C. Thompson

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Polyamines are essential for cell division and growth. Inhibition of polyamine biosynthesis by α-difluoromethylornithine (DFMO) on the growth of hamster H2T pancreatic cancer was investigated both in vitro and in vivo. Cell-doubling time (T(D)) was survival fraction were determined after a single treatment with DFMO (5 mM). We examined the ability of putrescine to reverse the growth-inhibitory effect of DFMO. The T(D) for cells treated with DFMO in vitro was 49.6 ± 5.7 versus 25.4 ± 2.6 hours for control. The addition of putrescine to DFMO-treated H2T cells showed a reversal of the growth-inhibitory effect of DFMO. Cytotoxicity in vitro increased with prolonged; the survival fraction after 24 hours of treatment was 32%; after 48 hours, 19%; after 72 hours, 13%; and after 92 hours, 8%. We performed two separate animal experiments. In experiment I, H2T cells were injected into the cheek pouch of male Syrian golden hamsters; controls did not receive DFMO. Continuous treatment with 3% DFMO in the drinking water was begun 7 days before, on the day of, or 7 days after tumor cell injection. In experiment II, 4 groups were treated identically to those in experiment I. An additional group of 10 hamsters received 3% DFMO and no tumor, and another additional group of 10 hamsters were housed individually with 3% DFMO begun 7 days after tumor cell injection. Tumor size, body weight, water, and food intake were measured. DFMO treatment in vivo significantly inhibited tumor size and inhibited growth of pancreatic cancer by as much as 50% of control. Our results demonstrate a significant antiproliferative effect of DFMO on the growth of pancreatic adenocarcinoma both in vitro and in vivo.

Original languageEnglish (US)
Pages (from-to)543-548
Number of pages6
JournalJournal of the National Cancer Institute
Volume79
Issue number3
StatePublished - 1987

Fingerprint

Eflornithine
Polyamines
Pancreatic Neoplasms
Cricetinae
Therapeutics
Growth
Putrescine
Neoplasms
Injections
Somatostatin-Secreting Cells
Body Water
Cheek
Mesocricetus
Drinking Water
Cell Division
Drinking

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Treatment of hamster pancreatic cancer with α-difluoromethylornithine, an inhibitor of polyamine biosynthesis. / Marx, Marilyn; Townsend, Courtney; Barranco, S. C.; Glass, E. J.; Thompson, J. C.

In: Journal of the National Cancer Institute, Vol. 79, No. 3, 1987, p. 543-548.

Research output: Contribution to journalArticle

@article{5d87b34e68a24311bc312399a198c8ea,
title = "Treatment of hamster pancreatic cancer with α-difluoromethylornithine, an inhibitor of polyamine biosynthesis",
abstract = "Polyamines are essential for cell division and growth. Inhibition of polyamine biosynthesis by α-difluoromethylornithine (DFMO) on the growth of hamster H2T pancreatic cancer was investigated both in vitro and in vivo. Cell-doubling time (T(D)) was survival fraction were determined after a single treatment with DFMO (5 mM). We examined the ability of putrescine to reverse the growth-inhibitory effect of DFMO. The T(D) for cells treated with DFMO in vitro was 49.6 ± 5.7 versus 25.4 ± 2.6 hours for control. The addition of putrescine to DFMO-treated H2T cells showed a reversal of the growth-inhibitory effect of DFMO. Cytotoxicity in vitro increased with prolonged; the survival fraction after 24 hours of treatment was 32{\%}; after 48 hours, 19{\%}; after 72 hours, 13{\%}; and after 92 hours, 8{\%}. We performed two separate animal experiments. In experiment I, H2T cells were injected into the cheek pouch of male Syrian golden hamsters; controls did not receive DFMO. Continuous treatment with 3{\%} DFMO in the drinking water was begun 7 days before, on the day of, or 7 days after tumor cell injection. In experiment II, 4 groups were treated identically to those in experiment I. An additional group of 10 hamsters received 3{\%} DFMO and no tumor, and another additional group of 10 hamsters were housed individually with 3{\%} DFMO begun 7 days after tumor cell injection. Tumor size, body weight, water, and food intake were measured. DFMO treatment in vivo significantly inhibited tumor size and inhibited growth of pancreatic cancer by as much as 50{\%} of control. Our results demonstrate a significant antiproliferative effect of DFMO on the growth of pancreatic adenocarcinoma both in vitro and in vivo.",
author = "Marilyn Marx and Courtney Townsend and Barranco, {S. C.} and Glass, {E. J.} and Thompson, {J. C.}",
year = "1987",
language = "English (US)",
volume = "79",
pages = "543--548",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Treatment of hamster pancreatic cancer with α-difluoromethylornithine, an inhibitor of polyamine biosynthesis

AU - Marx, Marilyn

AU - Townsend, Courtney

AU - Barranco, S. C.

AU - Glass, E. J.

AU - Thompson, J. C.

PY - 1987

Y1 - 1987

N2 - Polyamines are essential for cell division and growth. Inhibition of polyamine biosynthesis by α-difluoromethylornithine (DFMO) on the growth of hamster H2T pancreatic cancer was investigated both in vitro and in vivo. Cell-doubling time (T(D)) was survival fraction were determined after a single treatment with DFMO (5 mM). We examined the ability of putrescine to reverse the growth-inhibitory effect of DFMO. The T(D) for cells treated with DFMO in vitro was 49.6 ± 5.7 versus 25.4 ± 2.6 hours for control. The addition of putrescine to DFMO-treated H2T cells showed a reversal of the growth-inhibitory effect of DFMO. Cytotoxicity in vitro increased with prolonged; the survival fraction after 24 hours of treatment was 32%; after 48 hours, 19%; after 72 hours, 13%; and after 92 hours, 8%. We performed two separate animal experiments. In experiment I, H2T cells were injected into the cheek pouch of male Syrian golden hamsters; controls did not receive DFMO. Continuous treatment with 3% DFMO in the drinking water was begun 7 days before, on the day of, or 7 days after tumor cell injection. In experiment II, 4 groups were treated identically to those in experiment I. An additional group of 10 hamsters received 3% DFMO and no tumor, and another additional group of 10 hamsters were housed individually with 3% DFMO begun 7 days after tumor cell injection. Tumor size, body weight, water, and food intake were measured. DFMO treatment in vivo significantly inhibited tumor size and inhibited growth of pancreatic cancer by as much as 50% of control. Our results demonstrate a significant antiproliferative effect of DFMO on the growth of pancreatic adenocarcinoma both in vitro and in vivo.

AB - Polyamines are essential for cell division and growth. Inhibition of polyamine biosynthesis by α-difluoromethylornithine (DFMO) on the growth of hamster H2T pancreatic cancer was investigated both in vitro and in vivo. Cell-doubling time (T(D)) was survival fraction were determined after a single treatment with DFMO (5 mM). We examined the ability of putrescine to reverse the growth-inhibitory effect of DFMO. The T(D) for cells treated with DFMO in vitro was 49.6 ± 5.7 versus 25.4 ± 2.6 hours for control. The addition of putrescine to DFMO-treated H2T cells showed a reversal of the growth-inhibitory effect of DFMO. Cytotoxicity in vitro increased with prolonged; the survival fraction after 24 hours of treatment was 32%; after 48 hours, 19%; after 72 hours, 13%; and after 92 hours, 8%. We performed two separate animal experiments. In experiment I, H2T cells were injected into the cheek pouch of male Syrian golden hamsters; controls did not receive DFMO. Continuous treatment with 3% DFMO in the drinking water was begun 7 days before, on the day of, or 7 days after tumor cell injection. In experiment II, 4 groups were treated identically to those in experiment I. An additional group of 10 hamsters received 3% DFMO and no tumor, and another additional group of 10 hamsters were housed individually with 3% DFMO begun 7 days after tumor cell injection. Tumor size, body weight, water, and food intake were measured. DFMO treatment in vivo significantly inhibited tumor size and inhibited growth of pancreatic cancer by as much as 50% of control. Our results demonstrate a significant antiproliferative effect of DFMO on the growth of pancreatic adenocarcinoma both in vitro and in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0023197588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023197588&partnerID=8YFLogxK

M3 - Article

VL - 79

SP - 543

EP - 548

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 3

ER -